Skip to main content

Booth Bruce's Form 4 filing

Kymera Therapeutics, Inc. (KYMR) · filed Apr 16, 2026

Accession no.
0001451612-26-000004
Filed
Apr 16, 2026
Trade date
Apr 14-15, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $854.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Booth BruceCIK 0001451612Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 14, 2026Common StockMOption exerciseAcquired+4,159$14.18+$58,974.624,159Direct
Apr 14, 2026Common StockSSaleDisposed−4,159$89.97−$374,185.230Direct
Apr 15, 2026Common StockMOption exerciseAcquired+2,200$14.18+$31,1962,200Direct
Apr 15, 2026Common StockSSaleDisposed−2,200$89.95−$197,8900Direct
Apr 15, 2026Common StockSSaleDisposed−2,750$90.10−$247,7753,899,917Indirect
Apr 15, 2026Common StockSSaleDisposed−385$90.10−$34,688.5674,956Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 14, 2026Common StockMOption exerciseDisposed−4,159$0.00$07,841Direct
Apr 15, 2026Common StockMOption exerciseDisposed−2,200$0.00$05,641Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)